Hormone therapy has been the most misunderstood menopause treatment of the last twenty years. The 2002 Women's Health Initiative headlines scared a generation of women and clinicians away from a treatment the guidance has since put back on the table. Whether it is right for you is a question for your doctor, and this page is here so you can ask it well.
What the evidence actually says
The British Menopause Society's position is that for most women with symptoms who are under 60, or within ten years of their last period, the benefits of HRT outweigh the risks. On breast cancer, NICE's guideline NG23 says estrogen on its own is linked to little or no change in risk, that estrogen taken with a progestogen can carry an increase, and that any increase is tied to how long it is taken and falls again after stopping. It is not a blanket danger, and it is not nothing either; your own history is what decides it.
For women with a uterus, progesterone is added to protect the uterine lining. For those without a uterus, estrogen alone is typically used.
Who it helps most
Hot flushes and night sweats, vaginal dryness and urinary changes, and bone strength are where the guidance is most specific. NICE NG23 and the PMS 2026 recommendations list HRT as a first-line option for hot flushes and night sweats, and NICE says the risk of a fragility fracture is lower while HRT is being taken. NICE treats local (vaginal) estrogen separately: it can be used alone or alongside HRT, for as long as it is needed, and side effects from it are very rare. It is also the question most often left unasked.
Who should be cautious
Women with a personal history of breast cancer, blood clots, stroke, or active liver disease need an individualised conversation, sometimes a different class of medication entirely.
The point is not to push hormones on everyone. It is to replace fear with information so you can make the call that fits your body and your history.